Products from BPS Bioscience require a minimum order value above 400€
Application: Use as a control for studying the differences between HLA-B alleles. Study T cell activation and responses to peptides presented by HLA-B*08:01.
Background: Human Leukocyte Antigen-B (HLA-B) is an MHC-I (major histocompatibility complex) heavy chain receptor, composed of HLA-B and β2-microglobulin (B2M). There are over 200 genes encoding HLA variants and this variability plays a critical role in adaptive immunity. HLA-B has been linked to autoimmune disorders and drug reactions. HLA-B*08 has been linked to anti-carbamylated protein antibody-positive/anti-cyclic citrullinated peptide-negative RA (rheumatoid arthritis). HLA-B*08:01 has been identified as a unique genetic factor in EOMG (early-onset myasthenia graves). The understanding of the association between HLA alleles and diseases will allow a refinement of therapeutic strategies.
Description: The HLA-B*08:01 A549 Cell Line is an A549 human lung cancer cell line generated by selecting a single clone of B2M Knockout A549 cells (#82871) transduced with a lentivirus expressing B2M (beta-2 microglobulin) HLA (human leukocyte antigen)-B*08:01 driven by an EF1a promoter (#82429). This cell line has been validated by flow cytometry.
Host Cell Line: A549 is a human lung alveolar basal carcinoma cell line. Adherent epithelial cells.
Mycoplasma Testing: The cell line has been screened to confirm the absence of Mycoplasma species.
Storage Stability: Cells are shipped in dry ice and should immediately be thawed or stored in liquid nitrogen upon receipt. Do not use a -80°C freezer for long term storage.
Supplied As: Each vial contains ˃1 x 106 cells in 1 ml of Cell Freezing Medium (#79796)